Business Context and Reporting Period
Promis Neurosciences Inc. (PMN) filed this Form 8-K on July 10, 2023, to report a voluntary delisting of its common shares from the Toronto Stock Exchange (TSX). The company is incorporated in Canada and its common shares continue to be listed and traded on the Nasdaq Capital Market under the symbol "PMN."
Key Financial Metrics
This filing is a current report regarding a corporate event and does not contain financial statements. Consequently, the filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
- Delisting Approval: The Company received approval for a voluntary delisting from the TSX.
- Effective Date: The delisting is expected to be effective as of the close of trading on July 21, 2023.
- Trading Status: Shares will remain listed on Nasdaq following the TSX delisting.
Guidance, Outlook, and Risks
The filing does not include financial guidance, management commentary on future performance, or specific risk factors beyond the operational change of delisting from the TSX. The primary contingency noted is the transition of trading venue, which is expected to be completed by July 21, 2023.
Investor Verification Checklist
- Confirm the effective date of the TSX delisting (July 21, 2023).
- Verify continued trading status on the Nasdaq Capital Market under symbol "PMN."
- Review the attached press release (Exhibit 99.1) for additional context on the strategic rationale for the delisting.